Status:

ACTIVE_NOT_RECRUITING

A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants

Lead Sponsor:

Latigo Biotherapeutics

Conditions:

Healthy

Eligibility:

All Genders

18-55 years

Phase:

PHASE1

Brief Summary

This is a sequential, randomized, double-blind, placebo-controlled Phase 1 single (SAD) and multiple (MAD) ascending dose study to evaluate the safety, tolerability, and pharmacokinetics (PK) of orall...

Eligibility Criteria

Inclusion

  • Male and female participants aged 18 to 55 years, inclusive, at the time of signing the informed consent.
  • Overtly healthy with no clinically relevant abnormalities based on the medical history, physical examinations, clinical laboratory evaluations, and 12-lead ECG that, in the opinion of the investigator, would affect participant safety.
  • Body mass index (BMI) within the range of 18-32 kg/m2 (inclusive).

Exclusion

  • Inability to take oral medications or gastrointestinal abnormalities potentially impacting absorption
  • Clinically significant cardiovascular, hematological, renal, hepatic, pulmonary, endocrine, gastrointestinal, immunological, dermatological, neurological, or psychiatric disease which could interfere with, or the treatment for which might interfere with, the conduct of the study or which would, in the opinion of the investigator, unacceptably increase the participant's risk by participating in the study
  • Past or current history or evidence of alcohol abuse and/or dependence on recreational drug use
  • Donation of over 500 mL blood ≤ 3 months prior to start of participation
  • Has known psychiatric disorders that would interfere with the cooperation with the requirements of the study
  • Participant is under legal custodianship.

Key Trial Info

Start Date :

October 17 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 28 2026

Estimated Enrollment :

96 Patients enrolled

Trial Details

Trial ID

NCT06049095

Start Date

October 17 2023

End Date

February 28 2026

Last Update

September 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinical Research Unit

Christchurch, New Zealand